Morgan Stanley’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$246M Buy
4,519,684
+341,448
+8% +$16.6M 0.01% 896
2026
Q1
$179M Sell
4,178,236
-28,420
-0.7% -$1.22M 0.01% 1023
2025
Q4
$184M Buy
4,206,656
+995,949
+31% +$41.2M 0.01% 991
2025
Q3
$133M Sell
3,210,707
-367,968
-10% -$14.8M 0.01% 1182
2025
Q2
$158M Buy
3,578,675
+1,067,307
+42% +$42.7M 0.01% 1011
2025
Q1
$92.7M Sell
2,511,368
-241,205
-9% -$8.59M 0.01% 1304
2024
Q4
$91.7M Buy
2,752,573
+620,209
+29% +$20.1M 0.01% 1324
2024
Q3
$55.3M Sell
2,132,364
-151,073
-7% -$3.75M ﹤0.01% 1735
2024
Q2
$51.3M Sell
2,283,437
-2,410,410
-51% -$53.5M ﹤0.01% 1729
2024
Q1
$111M Sell
4,693,847
-80,884
-2% -$1.8M 0.01% 1109
2023
Q4
$115M Buy
4,774,731
+1,636,336
+52% +$35.6M 0.01% 1070
2023
Q3
$68.6M Buy
3,138,395
+551,074
+21% +$11.5M 0.01% 1311
2023
Q2
$49.4M Buy
2,587,321
+15,691
+0.6% +$302K ﹤0.01% 1585
2023
Q1
$49.9M Buy
2,571,630
+259,513
+11% +$4.52M 0.01% 1546
2022
Q4
$37.1M Buy
2,312,117
+1,009,945
+78% +$16.5M ﹤0.01% 1755
2022
Q3
$20.4M Sell
1,302,172
-292,781
-18% -$5.66M ﹤0.01% 2172
2022
Q2
$33.2M Buy
1,594,953
+743,318
+87% +$15.3M ﹤0.01% 1733
2022
Q1
$19.3M Buy
851,635
+39,960
+5% +$780K ﹤0.01% 2157
2021
Q4
$14.8M Buy
811,675
+28,789
+4% +$551K ﹤0.01% 2496
2021
Q3
$16.6M Buy
782,886
+20,764
+3% +$386K ﹤0.01% 2290
2021
Q2
$13.9M Buy
762,122
+274,652
+56% +$6.41M ﹤0.01% 2595
2021
Q1
$11M Sell
487,470
-71,784
-13% -$1.62M ﹤0.01% 2548
2020
Q4
$11.2M Buy
559,254
+191,941
+52% +$4.02M ﹤0.01% 2388
2020
Q3
$8.98M Sell
367,313
-18,126
-5% -$423K ﹤0.01% 2122
2020
Q2
$9.15M Sell
385,439
-158,575
-29% -$3.67M ﹤0.01% 2058
2020
Q1
$9.37M Sell
544,014
-62,323
-10% -$1.14M ﹤0.01% 1839
2019
Q4
$10.7M Buy
606,337
+67,916
+13% +$1.15M ﹤0.01% 2372
2019
Q3
$9.52M Sell
538,421
-693,346
-56% -$14M ﹤0.01% 2181
2019
Q2
$26.3M Sell
1,231,767
-266,717
-18% -$5.59M 0.01% 1280
2019
Q1
$35.7M Buy
1,498,484
+320,569
+27% +$7.31M 0.01% 1043
2018
Q4
$23.2M Buy
1,177,915
+579,810
+97% +$10.3M 0.01% 1341
2018
Q3
$10.6M Sell
598,105
-21,191
-3% -$413K ﹤0.01% 2356
2018
Q2
$13.3M Sell
619,296
-464,259
-43% -$9.6M ﹤0.01% 2054
2018
Q1
$24M Buy
1,083,555
+73,448
+7% +$2.03M 0.01% 1504
2017
Q4
$30.7M Buy
1,010,107
+167,879
+20% +$4.47M 0.01% 1316
2017
Q3
$20.4M Buy
842,228
+239,777
+40% +$6.38M 0.01% 1564
2017
Q2
$14.8M Sell
602,451
-84,139
-12% -$1.78M ﹤0.01% 1794
2017
Q1
$14.9M Sell
686,590
-943,873
-58% -$19.2M ﹤0.01% 1818
2016
Q4
$24.3M Buy
1,630,463
+872,566
+115% +$12.6M 0.01% 1363
2016
Q3
$9.69M Buy
757,897
+360,538
+91% +$3.9M ﹤0.01% 2037
2016
Q2
$3.1M Buy
397,359
+69,918
+21% +$403K ﹤0.01% 3045
2016
Q1
$1.31M Sell
327,441
-8,345
-2% -$35.3K ﹤0.01% 3705
2015
Q4
$1.89M Sell
335,786
-219,589
-40% -$1.23M ﹤0.01% 3541
2015
Q3
$3.12M Buy
555,375
+365,485
+192% +$1.99M ﹤0.01% 3084
2015
Q2
$714K Sell
189,890
-254,983
-57% -$829K ﹤0.01% 4451
2015
Q1
$1.14M Sell
444,873
-976,060
-69% -$2.27M ﹤0.01% 4026
2014
Q4
$2.05M Buy
1,420,933
+1,248,770
+725% +$1.95M ﹤0.01% 3543
2014
Q3
$263K Sell
172,163
-118,549
-41% -$381K ﹤0.01% 4992
2014
Q2
$985K Sell
290,712
-20,477
-7% -$70.7K ﹤0.01% 4064
2014
Q1
$1.1M Buy
311,189
+102,286
+49% +$696K ﹤0.01% 3905
2013
Q4
$1.28M Sell
208,903
-45,094
-18% -$248K ﹤0.01% 3733
2013
Q3
$1.48M Buy
253,997
+33,772
+15% +$175K ﹤0.01% 3473
2013
Q2
$999K Buy
+220,225
New +$1.04M ﹤0.01% 3732

Other funds holding EXEL

Morgan Stanley's EXEL Position: Q2 2026 in Review

Morgan Stanley increased its Exelixis (EXEL) stake by 8.2% in Q2 2026, buying an estimated $16.6M and bringing the position to 4,519,684 shares worth $246M. The position accounts for 0.01% of the portfolio, ranked #896.

Morgan Stanley first reported a position in EXEL in Q2 2013 and has held it in 53 quarters since. 756 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Morgan Stanley held 4,519,684 shares of Exelixis worth $246M as of Q2 2026.
  • Morgan Stanley bought 341,448 Exelixis shares in Q2 2026, an estimated $16.6M.
  • Exelixis made up 0.01% of Morgan Stanley's portfolio in Q2 2026, its #896 holding.
  • Morgan Stanley first reported a position in Exelixis in Q2 2013 and has held it in 53 quarters since.
  • 756 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.